NEPH Insider Trading
Insider Ownership Percentage: 4.10%
Insider Buying (Last 12 Months): $123,160.00
Insider Selling (Last 12 Months): $0.00
Nephros Share Price & Price History
Current Price: $2.01
Price Change: ▲ Price Increase of +0.0476 (2.43%)
As of 04/25/2025 04:57 PM ET
Nephros Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/30/2024 | Arthur H Amron | Director | Buy | 3,000 | $2.24 | $6,720.00 | 103,463 |  |
| 5/28/2024 | Arthur H Amron | Director | Buy | 2,000 | $2.22 | $4,440.00 | 100,463 | |
| 5/16/2024 | Robert R Jr. Banks | CEO | Buy | 50,000 | $2.24 | $112,000.00 | 70,000 | |
| 12/7/2023 | Robert R Jr. Banks | CEO | Buy | 18,000 | $2.20 | $39,600.00 | 20,000 | |
| 8/14/2023 | Robert R Jr. Banks | CEO | Buy | 99 | $1.50 | $148.50 | 99 | |
Nephros Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/14/2025 | Topline Capital Management LLC | 419,887 | $0.62M | 0.1% | N/A | 3.984% |  |
| 2/6/2025 | Bard Associates Inc. | 155,271 | $0.23M | 0.1% | -9.9% | 1.473% | |
| 8/9/2024 | Dimensional Fund Advisors LP | 17,631 | $37K | 0.0% | N/A | 0.167% | |
| 4/26/2024 | Mesirow Financial Investment Management Inc. | 15,383 | $34K | 0.0% | N/A | 0.146% | |
| 2/10/2023 | Bard Associates Inc. | 194,789 | $0.23M | 0.1% | -22.7% | 1.887% | |
| 11/15/2022 | Elkhorn Partners Limited Partnership | 50,341 | $46K | 0.0% | +48.1% | 0.488% | |
| 8/11/2022 | Bard Associates Inc. | 263,754 | $0.40M | 0.2% | +7.0% | 2.556% | |
| 8/1/2022 | Cowen Prime Advisors LLC | 42,500 | $65K | 0.0% | -47.1% | 0.412% | |
| 5/23/2022 | Cantor Fitzgerald L. P. | 12,813 | $56K | 0.0% | N/A | 0.124% | |
| 5/11/2022 | Bard Associates Inc. | 246,408 | $1.08M | 0.4% | +6.0% | 2.388% | |
| 5/10/2022 | Elkhorn Partners Limited Partnership | 23,712 | $0.10M | 0.1% | +56.0% | 0.230% | |
| 5/2/2022 | Cowen Prime Advisors LLC | 80,400 | $0.35M | 0.1% | -87.3% | 0.780% | |
| 2/19/2022 | Wexford Capital LP | 3,650,529 | $646.53M | 27.0% | N/A | 35.674% | |
| 2/14/2022 | Elkhorn Partners Limited Partnership | 15,200 | $90K | 0.1% | +78.8% | 0.149% | |
| 2/8/2022 | Cowen Prime Advisors LLC | 633,050 | $3.74M | 1.3% | -4.1% | 6.186% | |
| 2/8/2022 | Samjo Capital LLC | 425,000 | $2.51M | 1.7% | -22.7% | 4.153% | |
| 11/9/2021 | BlackRock Inc. | 18,079 | $0.16M | 0.0% | -23.0% | 0.177% | |
| 11/2/2021 | Cowen Prime Advisors LLC | 660,150 | $5.79M | 2.2% | +5.4% | 6.461% | |
| 8/17/2021 | Wexford Capital LP | 3,631,197 | $36.85M | 5.6% | +1.9% | 35.541% | |
| 8/13/2021 | Vanguard Group Inc. | 99,936 | $1.01M | 0.0% | +3.9% | 0.978% | |
| 8/12/2021 | Bard Associates Inc. | 231,508 | $2.35M | 0.8% | +5.5% | 2.266% | |
| 8/4/2021 | Cowen Prime Advisors LLC | 626,450 | $6.36M | 2.3% | N/A | 6.290% | |
| 8/2/2021 | Advisor Group Holdings Inc. | 4,574 | $46K | 0.0% | +91,380.0% | 0.046% | |
| 5/21/2021 | Citadel Advisors LLC | 18,421 | $0.12M | 0.0% | N/A | 0.185% | |
| 5/18/2021 | Millennium Management LLC | 18,909 | $0.13M | 0.0% | -10.4% | 0.190% | |
| 5/18/2021 | Citadel Advisors LLC | 18,421 | $0.12M | 0.0% | N/A | 0.185% | |
| 5/13/2021 | Wexford Capital LP | 3,564,530 | $23.70M | 3.5% | +0.1% | 35.781% | |
| 5/7/2021 | BlackRock Inc. | 23,559 | $0.16M | 0.0% | +20.9% | 0.237% | |
| 4/27/2021 | Cowen Prime Services LLC | 622,750 | $4.14M | 1.6% | +8.3% | 6.258% | |
Data available starting January 2016
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Read More on Nephros
Volume
3,548 shs
Average Volume
12,555 shs
Market Capitalization
$21.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.05
Who are the company insiders with the largest holdings of Nephros?
